Down 52%, Is TransMedics Stock a Buy on the Dip? [Yahoo! Finance]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
A third-quarter earnings miss sent shares of the organ-transplant equipment and service provider reeling. By lunchtime on Nov. 7, the stock was 51.5% below its previous peak. Hospitals and organ transplant centers increasingly rely on TransMedics' proprietary organ care system (OCS). Is the latest stock-market beatdown an opportunity to buy a quality growth stock at a steep discount? Here's a closer look at why shares tanked, and at the company's path forward, to see whether it's a smart buy now. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » On Oct. 28, TransMedics reported third-quarter revenue that shot 64% higher year over year to $108.8 million. This hardly seems like a reason to complain, but it was $6.2 million below consensus estimates and $5.5 million less than the company reported in the second quarter. The bottom line disappointed investors even further. Wall Street was expecting earnings to reach $0.29 pe
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $180.00 to $110.00. They now have an "overweight" rating on the stock.MarketBeat
- TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $109.00 to $104.00. They now have a "buy" rating on the stock.MarketBeat
- Lightning Round: Coterra Energy is far superior to Devon Energy [CNBC]CNBC
- TransMedics to Participate in the Piper Sandler 36th Annual Healthcare ConferencePR Newswire
- TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at TD Cowen from $175.00 to $120.00. They now have a "buy" rating on the stock.MarketBeat
TMDX
Earnings
- 10/28/24 - Miss
TMDX
Sec Filings
- 11/13/24 - Form 4
- 11/7/24 - Form 4
- 11/5/24 - Form 4
- TMDX's page on the SEC website